Oncternal Therapeutics, Inc. - COM NEW (ONCT)

Historical Portfolio Holders from Q4 2023 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
483K
Holdings value Q2 2024
$3.67M
Value change Q2 2024
+$248K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
26
Number of buys Q2 2024
0
Number of sells Q2 2024
-4
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 13.5K $17.8K -$347K $1.32 3
2024 Q2 483K $3.67M +$248K $7.60 26
2024 Q1 450K $4.05M +$3.97M $9.00 24
2023 Q4 59K $31.7K +$31.7K $0.54 4